Form 4: Relmada Therapeutics Director Charles J. Casamento Reports Ownership Change
SEC Form 4 Filing
Director Charles J. Casamento reports a disposition of 13,000 common stock shares of Relmada Therapeutics, Inc. through a gift.
Summary
- On October 22, 2024, Charles J. Casamento, a director of Relmada Therapeutics, Inc., reported a change in beneficial ownership of the company's common stock.
- The transaction involved the disposition of 13,000 shares of common stock through a gift.
- Following the transaction, Mr. Casamento directly owns 0 shares of Relmada Therapeutics, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a change in ownership. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The change in ownership may have a minor impact on shareholder sentiment, but the gift of shares by a director is unlikely to have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 10/22/2024 | Date of transaction: Charles J. Casamento disposed of 13,000 shares of Relmada Therapeutics common stock via a gift. |
| 10/23/2024 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, RLMD, Relmada Therapeutics, Casamento, Director, Common Stock, Gift
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.